Skip to main content
SURG
NASDAQ Technology

SurgePays Faces Nasdaq Delisting Risk, Issues $1M in Shares to CEO for Debt

Analysis by Wiseek.aiReviewed by Editorial Team
Sentiment info
Negative
Importance info
9
Price
$0.87
Mkt Cap
$20.609M
52W Low
$0.752
52W High
$3.47
Market data snapshot near publication time

summarizeSummary

SurgePays received Nasdaq delisting notices for failing to meet minimum market value and bid price requirements, while also issuing $1 million in shares to its CEO to settle debt.


check_boxKey Events

  • Nasdaq Delisting Notices Received

    The company received notices for failing to meet Nasdaq's minimum market value of listed securities ($35M) and minimum bid price ($1.00) requirements. It has 180 days to regain compliance for each, with potential delisting if unsuccessful.

  • Significant Share Issuance to CEO

    800,000 shares were issued to CEO and Chairman Brian Cox at $1.25 per share, valued at $1,000,000, to satisfy an outstanding promissory note. This represents a substantial issuance relative to the company's size.


auto_awesomeAnalysis

SurgePays, Inc. has received dual notices from Nasdaq for failing to meet both the minimum market value of listed securities ($35 million) and the minimum bid price ($1.00) requirements. The company's current market capitalization is significantly below the MVLS threshold, and its stock price is below the bid price. Failure to regain compliance within 180 days could lead to delisting, severely impacting liquidity and future capital-raising efforts. Concurrently, the company issued 800,000 shares to its CEO and Chairman, Brian Cox, at $1.25 per share to satisfy a $1 million debt. While this reduces company liabilities, it represents substantial dilution relative to the company's small market cap and occurs at a critical time when the company needs to boost its stock price and market value to avoid delisting.

At the time of this filing, SURG was trading at $0.87 on NASDAQ in the Technology sector, with a market capitalization of approximately $20.6M. The 52-week trading range was $0.75 to $3.47. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed SURG - Latest Insights

SURG
Apr 27, 2026, 4:30 PM EDT
Filing Type: PRE 14A
Importance Score:
8
SURG
Apr 15, 2026, 5:30 PM EDT
Filing Type: 10-K
Importance Score:
9
SURG
Apr 14, 2026, 4:05 PM EDT
Source: GlobeNewswire
Importance Score:
8
SURG
Mar 24, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
9
SURG
Jan 22, 2026, 12:10 PM EST
Filing Type: 424B5
Importance Score:
9
SURG
Jan 22, 2026, 11:59 AM EST
Filing Type: 8-K
Importance Score:
8
SURG
Jan 21, 2026, 9:39 PM EST
Filing Type: 424B5
Importance Score:
8
SURG
Jan 20, 2026, 5:01 PM EST
Filing Type: 424B5
Importance Score:
8
SURG
Jan 14, 2026, 4:15 PM EST
Filing Type: 8-K
Importance Score:
7
SURG
Jan 07, 2026, 4:55 PM EST
Filing Type: 8-K
Importance Score:
7